Establishment of new amniotic fluid biomarkers that reflect fetal prognosis including fetal growth restriction

Establishment of new amniotic fluid biomarkers that reflect fetal prognosis including fetal growth restriction children - Establishment of new amniotic fluid biomarkers that reflect fetal prognosis including fetal growth restriction children

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045506

Enrollment

Registered

2021-09-17

Start date

2021-08-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetus in a single pregnancy, including fetal growth restriction.

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Fetus in a single pregnancy, including fetal growth restriction

Exclusion criteria

Exclusion criteria: multiple pregnancy chromosomal abnormalities, genetic disorders abruption of placenta, prolapse of umbilical cord, non reassuring fetal status, massive genital hemorrhage due to placenta previa, uterine rupture, and other feto-maternal emergent status

Design outcomes

Primary

Measure	Time frame
To investigate the relationship between amniotic fluid L-type fatty acid-binding protein and neutrophil gelatinase-associated lipocalin and short-term (fetal death, placental insufficiency, transient tachypnea of the newborn, respiratory distress syndrome, artificial respiration, chronic lung disease, cerebral hemorrhage, periventricular leukomalacia, necrotizing enterocolitis, retinopathy of prematurity and neonatal death) and long-term prognosis (Cerebral palsy, short stature and developmental regression ).	—

Measure

Time frame

To investigate the relationship between amniotic fluid L-type fatty acid-binding protein and neutrophil gelatinase-associated lipocalin and short-term (fetal death, placental insufficiency, transient tachypnea of the newborn, respiratory distress syndrome, artificial respiration, chronic lung disease, cerebral hemorrhage, periventricular leukomalacia, necrotizing enterocolitis, retinopathy of prematurity and neonatal death) and long-term prognosis (Cerebral palsy, short stature and developmental regression ).

—

Countries

Japan

Contacts

Public ContactDaisuke Katsura

Shiga University of Medical Science Department of Obstetrics and Gynecology

katsuo14@belle.shiga-med.ac.jp077-548-2267

Outcome results